These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 14560574

  • 21. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
    Takahashi R, Shimazaki C, Inaba T, Nakagawa M, Yamaoka M.
    Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
    [Abstract] [Full Text] [Related]

  • 22. Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
    Chiorean EG, DeFor TE, Weisdorf DJ, Blazar BR, McGlave PB, Burns LJ, Brown C, Miller JS.
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):171-7. PubMed ID: 14993882
    [Abstract] [Full Text] [Related]

  • 23. Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells.
    Rapoport AP, Levine BL, Badros A, Meisenberg B, Ruehle K, Nandi A, Rollins S, Natt S, Ratterree B, Westphal S, Mann D, June CH.
    Bone Marrow Transplant; 2004 Jan; 33(1):53-60. PubMed ID: 14578928
    [Abstract] [Full Text] [Related]

  • 24. Successful bone marrow transplantation from an unrelated donor in a patient with adult T cell leukemia.
    Ogata M, Ogata Y, Imamura T, Ohtsuka E, Kikuchi H, Utsunomiya A, Yashiki S, Sonoda S, Nasu M.
    Bone Marrow Transplant; 2002 Nov; 30(10):699-701. PubMed ID: 12420209
    [Abstract] [Full Text] [Related]

  • 25. Outcome of hematopoietic stem cell transplantation in patients with atypical chronic myeloid leukemia.
    Koldehoff M, Beelen DW, Trenschel R, Steckel NK, Peceny R, Ditschkowski M, Ottinger H, Elmaagacli AH.
    Bone Marrow Transplant; 2004 Dec; 34(12):1047-50. PubMed ID: 15516946
    [Abstract] [Full Text] [Related]

  • 26. Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation.
    Kumar A, Styler MJ, Topolsky DL, Crilley PA, Przybysz TM, Gladstone DE.
    Am J Hematol; 2002 Nov; 71(3):227-8. PubMed ID: 12410583
    [Abstract] [Full Text] [Related]

  • 27. T-cell receptor gammadelta-large granular lymphocytic leukemia associated with an aberrant phenotype and TCR-Vbeta20 clonality.
    Vartholomatos G, Alymara V, Dova L, Kolaitis N, Bourantas KL.
    Haematologica; 2004 May; 89(5):ECR16. PubMed ID: 15136245
    [Abstract] [Full Text] [Related]

  • 28. A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.
    Weisser M, Tischer J, Schnittger S, Schoch C, Ledderose G, Kolb HJ.
    Haematologica; 2006 May; 91(5):663-6. PubMed ID: 16627251
    [Abstract] [Full Text] [Related]

  • 29. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
    DeAngelo DJ, Hochberg EP, Alyea EP, Longtine J, Lee S, Galinsky I, Parekkedon B, Ritz J, Antin JH, Stone RM, Soiffer RJ.
    Clin Cancer Res; 2004 Aug 01; 10(15):5065-71. PubMed ID: 15297408
    [Abstract] [Full Text] [Related]

  • 30. Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia.
    Kobbe G, Fenk R, Neumann F, Bernhardt A, Steidl U, Kondakci M, Graef T, Aivado M, Vaupel M, Huenerlituerkoglu AN, Kronenwett R, Pape H, Hildebrand B, Germing U, Haas R.
    Cytotherapy; 2004 Aug 01; 6(6):533-42. PubMed ID: 15764020
    [Abstract] [Full Text] [Related]

  • 31. Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion.
    Levenga H, Woestenenk R, Schattenberg AV, Maas F, Jansen JH, Raymakers R, De Mulder PH, van de Wiel-van Kemenade E, Schaap N, de Witte T, Dolstra H.
    Bone Marrow Transplant; 2007 Sep 01; 40(6):585-92. PubMed ID: 17637687
    [Abstract] [Full Text] [Related]

  • 32. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S.
    Natl Med J India; 2004 Sep 01; 17(2):71-3. PubMed ID: 15141598
    [Abstract] [Full Text] [Related]

  • 33. T cell large granular lymphocyte leukemia associated with rheumatoid arthritis and neutropenia.
    Shah A, Diehl LF, St Clair EW.
    Clin Immunol; 2009 Aug 01; 132(2):145-52. PubMed ID: 19394280
    [Abstract] [Full Text] [Related]

  • 34. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.
    Ewing P, Miklos S, Olkiewicz KM, Müller G, Andreesen R, Holler E, Cooke KR, Hildebrandt GC.
    Exp Hematol; 2007 Jan 01; 35(1):155-63. PubMed ID: 17198884
    [Abstract] [Full Text] [Related]

  • 35. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.
    Chen J, Schmitt A, Bunjes D, Chen B, Schmitt M.
    Int J Oncol; 2007 May 01; 30(5):1119-27. PubMed ID: 17390013
    [Abstract] [Full Text] [Related]

  • 36. Rituximab-induced acute liver failure after an allogeneic transplantation for chronic myeloid leukemia.
    Qazilbash MH, Qu Z, Hosing C, Couriel D, Donato M, Giralt S, Champlin R.
    Am J Hematol; 2005 Sep 01; 80(1):43-5. PubMed ID: 16138357
    [Abstract] [Full Text] [Related]

  • 37. [Prediction of T-cell immune reconstitution by investigating T cell receptor excision circle and T-cell receptor beta-chain variable region clonal repertoire in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW, Wu DP, Cen JN, Feng YF, Chang WR, Qiu QC, Zhu ZL, Zhu P.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2265-7. PubMed ID: 18001548
    [Abstract] [Full Text] [Related]

  • 38. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
    Gomyo H, Murayama T, Kizaki T, Mizuno I, Kitaori K, Sao H, Tobinai K, Koizumi K, Imoto S.
    Bone Marrow Transplant; 2000 Sep 28; 26(5):577-9. PubMed ID: 11019851
    [Abstract] [Full Text] [Related]

  • 39. Development of donor cell derived acute myeloid leukemia after stem cell transplantation for chronic myeloid leukemia.
    Pieroni F, Oliveira FM, Panepucci RA, Voltarelli JC, Simões BP, Falcão RP.
    Bone Marrow Transplant; 2006 Apr 28; 37(8):801-2. PubMed ID: 16501585
    [No Abstract] [Full Text] [Related]

  • 40. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
    Sugimoto T, Imoto S, Matsuo Y, Kojima K, Yasukawa M, Murayama T, Kohfuku J, Mizuno I, Yakushijin K, Sada A, Nishimura R, Koizumi T.
    Ann Hematol; 2001 Dec 28; 80(12):749-51. PubMed ID: 11797117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.